WHO ICTRP trial

Investigating the effect of PRP and mesenchymal stem cells on improving the…

IRCT20230208057351N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20230208057351N1
Public title Investigating the effect of PRP and mesenchymal stem cells on improving the motor function of stroke patients
Scientific title Investigating the effect of PRP and mesenchymal stem cells on improving the motor function of stroke patients
Primary sponsor Tehran University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 1
Countries Iran (Islamic Republic of)
Conditions stroke. Stroke, not specified as haemorrhage or infarction
Interventions Intervention 1: Intervention group 1: PRP therapy group will receive one intramuscular injection of autologous platelet-rich plasma (PRP) in their biceps brachii muscle. PRP is extracted from autologous patient blood using one step or more…
Registration date Feb 15, 2023
Target size 15
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations